Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

Title
Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 10, Issue 3, Pages 503-512
Publisher
Informa Healthcare
Online
2009-02-04
DOI
10.1517/14656560802694713

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started